The introduction of fast scintillators with good stopping power for 511-keV photons has
renewed interest in time-of-flight (TOF) PET. The ability to measure the difference between the …

PET and 18 F-FDG have the potential to follow the early metabolic response to chemotherapy
in patients with non–small cell lung cancer and to predict success or failure of the therapy. …

PURPOSE: To investigate the role of 18-fluorine-fluorodeoxyglucose positron emission
tomography/computerized tomography ( 18 F-FDG PET/CT) in the preoperative prediction of the …

Care of patients with AL amyloidosis currently is limited by the lack of objective means to
document disease extent, as well as therapeutic options that expedite removal of pathologic …

In patients with oral head and neck cancer, the presence of metallic dental implants produces
streak artifacts in the CT images. These artifacts negate the utility of CT for the spatial …

Palladia TM (toceranib phosphate—Pfizer Animal Health) is a novel orally administered
receptor tyrosine kinase inhibitor (TKI) approved for treatment of canine mast cell tumors. …

Extravasation during radiopharmaceutical injection may occur with a frequency of more than
10%. In these cases, radioactivity remains within tissue and deposits unintended radiation …

PURPOSE: To determine whether the time course of 18-fluorine fluorodeoxyglucose (18F-FDG)
activity in multiple consecutively obtained 18 F-FDG positron emission tomography (PET)…

Cardiac PET/CT is an evolving, non-invasive imaging modality that impacts patient
management in many clinical scenarios. Beyond offering the capability to assess myocardial …

Standard whole-body PET/CT protocols collect PET emission data for a sequence of discrete,
overlapping bed positions. An alternative acquisition mode in which the patient bed moves …